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Abstract
Background: Breathing motion should be considered for stereotactic body radiotherapy (SBRT) of lung
tumors. Four-dimensional computer tomography (4D-CT) offers detailed information of tumor motion.
The aim of this work is to evaluate the influence of inhomogeneous dose distributions in the presence of
breathing induced target motion and to calculate margins for motion compensation.
Methods: Based on 4D-CT examinations, the probability density function of pulmonary tumors was
generated for ten patients. The time-accumulated dose to the tumor was calculated using one-dimensional
(1D) convolution simulations of a 'static' dose distribution and target probability density function (PDF).
In analogy to stereotactic body radiotherapy (SBRT), different degrees of dose inhomogeneity were
allowed in the target volume: minimum doses of 100% were prescribed to the edge of the target and
maximum doses varied between 102% (P102) and 150% (P150). The dose loss due to breathing motion
was quantified and margins were added until this loss was completely compensated.
Results: With the time-weighted mean tumor position as the isocentre, a close correlation with a
quadratic relationship between the standard deviation of the PDF and the margin size was observed.
Increased dose inhomogeneity in the target volume required smaller margins for motion compensation:
margins of 2.5 mm, 2.4 mm and 1.3 mm were sufficient for compensation of 11.5 mm motion range and
standard deviation of 3.9 mm in P105, P125 and P150, respectively. This effect of smaller margins for
increased dose inhomogeneity was observed for all patients. Optimal sparing of the organ-at-risk
surrounding the target was achieved for dose prescriptions P105 to P118. The internal target volume
concept over-compensated breathing motion with higher than planned doses to the target and increased
doses to the surrounding normal tissue.
Conclusion: Treatment planning with inhomogeneous dose distributions in the target volume required
smaller margins for compensation of breathing induced target motion with the consequence of lower
doses to the surrounding organs-at-risk.
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Background
The process of treatment planning and dose calculation in
radiation therapy is currently based on a three-dimen-
sional (3D) patient model. Temporal changes of the
patients' anatomy due to breathing motion for e.g. lung
tumors are not easily accounted for [1]. The use of stand-
ard, population based margins has been shown to be
insufficient for a considerable proportion of the patients
[2]. Different strategies have been developed for quantifi-
cation of breathing motion [3-5] and for integration of
the motion information into the planning and treatment
workflow [6-12].
Non-gated treatment of the patient breathing freely with-
out tumor tracking is the most straightforward technique:
the requirements on the patients' pulmonary function
and cooperation are low, the irradiation is performed con-
tinuously resulting in short total treatment times and no
specific technical equipment is required. However, precise
assessment of breathing induced target motion and calcu-
lation of adequate safety margins are essential for this
technique.
Four-dimensional respiratory correlated computed tom-
ography (4D-CT) is considered as the standard to gain
detailed information about range and pattern of breath-
ing induced organ motion [13,14]. The next step is the
integration of this temporal dimension into the process of
dose calculation and treatment planning. A straightfor-
ward approach to approximate the effect of tumor motion
on the dose distribution is convolving a static dose distri-
bution with a matrix containing the probability density
function (PDF) of the moving organ [15-22].
Engelsman et. al [23] used this method to investigate the
influence of breathing induced motion of pulmonary
tumors and to calculate margins for compensation of this
uncertainty. The margin was described by the displace-
ment of the 95% isodose in the blurred dose profile com-
pared to the static dose profile. That study was analogous
to current clinical practice in fractionated radiotherapy,
where the target volume is treated with a homogenous
dose distribution.
However, for some clinical indications like cranial and
extracranial stereotactic radiotherapy, inhomogeneous
dose distributions are commonly used. In pulmonary ster-
eotactic body radiotherapy (SBRT) the degree of dose
inhomogeneity in the target volume varies widely: doses
are prescribed to the 50%, 60%, 65%, 80%, 85% or 90%
isodose [24,25]. Motion of the target in such inhomoge-
neous dose distributions is expected to yield different
results compared to simulations based on a homogenous
dose distribution.
It was the aim of the current work to simulate the effect of
tumor motion in inhomogeneous dose distributions.
Inhomogeneous dose distributions were generated by
field size reduction without intensity modulation. The
convolution model was used to simulate the motion of a
target in a homogeneous medium and the motion simu-
lation was focused on respiratory motion while setup
errors were ignored. The decrease of treatment dose in the
target due to motion was evaluated and margins for com-
pensation of breathing motion were calculated. Different
degrees of dose inhomogeneity in the target for a single
beam profile were used. The results of this study are
expected to be of clinical relevance especially for confor-
mal stereotactic body radiotherapy of pulmonary and
intra-hepatic lesions.
Methods
The investigations of this study are based on real patient
data: ten consecutive patients (age 67 ± 6 years, female 3,
male 7) treated with SBRT for early stage non-small cell
lung cancer or pulmonary metastases. Written informed
consent was obtained from all patients.
For all ten patients a respiratory correlated 4D-CT study
was acquired for treatment planning (Siemens Sensation
Open; Siemens Medical Solutions, Erlangen, Germany).
Details about 4D-CT image acquisition and image recon-
struction have been described previously [24]. The
motion range of the pulmonary target was evaluated after
reconstruction of CT series in peak-inhalation and peak-
exhalation. The motion of the tumor in the predominant
direction was chosen for one-dimensional (1D) simula-
tions: this was the superior-inferior direction in all
patients. A pressure sensor placed in an elastic belt around
the patient's abdomen generated the external breathing
signal (Anzai AZ-733V; Anzai Medical Solutions, Japan).
The external breathing signal recorded during acquisition
of the 4D-CT study was the basis for the calculation of the
tumor PDF; the range of the PDF was equated with the
maximum motion range of the tumor measured in the
4D-CT (Figure 1).
The patient specific parameters are listed in table 1;
breathing motion was quantified by the range of the PDF
(AMax), standard deviation (Eq. 1) of the PDF (σPDF) and
the time-weighted mean target position (PMean). The
standard deviation of the motion signal P was calculated
using the position sample (Pi), the mean target position
(PMean) and the number of elements in the sample (n).
σ PDF =
−
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Probability density functions of the pulmonary tumor for the 10 patients (exhalation and inhalation position have negative and  positive numbers) Figure 1
Probability density functions of the pulmonary tumor for the 10 patients (exhalation and inhalation position 
have negative and positive numbers). The zero position is the geometrical centre of the PDF and the mean target posi-
tion (PMean) is marked with an arrow.
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A 1D convolution model was used to investigate the dosi-
metric influence of breathing induced tumor motion. The
model was implemented in Matlab™ (The MathWorks,
Inc., Natick, MA, USA) and allowed the variation of the
following parameters: dose profile, field size, target size,
motion range and shape of the PDF.
Dose profiles were generated by convolving an intensity
profile with a pencil beam kernel while a homogeneous
medium was assumed [26]. The intensity profile was a
square profile simulating an open field shape. To ensure
the correctness of the computed dose profiles, a compari-
son with measured profiles in a water phantom was per-
formed with the following parameters: field size 24 × 24
mm, depth 50 mm, machine Elekta Synergy S equipped
with the BeamModulator with 4 mm leaf width (Elekta
Oncology Systems, Crawley, UK) and photon energy 6
MV. The calculated and measured dose profiles were in
good agreement with 0.07% mean error normalized to
maximum value. The resolution of the simulated dose
profiles was 0.1 mm.
Assuming no breathing motion, a minimum dose of
100% was prescribed to the edge of the static target in the
time-weighted average position PMean. The centre of the
target in this time-weighted average position was the iso-
centre as suggested by Wolthaus et al. [27]. According to
the SBRT, different degrees of dose inhomogeneity in the
target volume were simulated. The maximum dose in the
tumor was varied between 102% and 150%. The dose
inhomogeneity was achieved by variation of the field size
only, no step-and-shoot segments for intensity modula-
tion were used. Figure 2 displays the prescription types
P105, P125 and P150 while P105 corresponds to a plan
with a minimum dose of 100% and a maximum dose of
105% within the target volume.
The time accumulated dose profile Dacc was calculated by
convolving the static reference dose profile D0(x) with the
variation kernel PDF(x).
This resulted in a blurring of the dose gradient and conse-
quently reduced the accumulated dose to the target vol-
ume (Figure 3a). For quantification of the motion effect,
the dose to the static target was compared with the dose
after motion simulation. The minimum dose to the target
(DMin) was considered as the treatment dose. Then, field
sizes were symmetrically enlarged in steps of 0.1 mm until
the dose reduction due to breathing motion was com-
pletely compensated (Figure 3b). The position of the dose
profile was shifted and optimized until the tumor received
equal doses to the edges. A margin was defined as the
increase in field size in one direction; the total increase in
field size is consequently twice the one-sided margin. This
target volume concept for compensation of breathing
motion was termed as "optimization of the surrounding
isodose" (OSI concept). Additional blurring of the dose
profile due to setup errors were not considered in this
work.
Additionally, the influence of motion on the dose to the
region surrounding the tumor (organs-at-risk lung or
liver) was investigated. This region corresponds to the pul-
monary/hepatic tissue superior and inferior to the target
in a 1D patient model, because target motion in superior-
inferior direction was modelled. In real patient treatment,
a significant dose is delivered to healthy tissue in the
entrance and exit regions of the beam (axial direction)
assuming a predominant coplanar beam set-up. This is
not considered in a 1D model. Consequently, doses to the
surrounding organ-at-risk were transformed into a 2D
model in a sagittal plane: with a coplanar opposing field
design, the dose distribution in superior-inferior direction
was extrapolated in anterior-posterior direction. Doses in
a 2D sagittal plane with extensions of 15 cm in superior-
inferior and 12 cm anterior-posterior direction were calcu-
lated, respectively; the dose inside the target (equal tumor
size in superior-inferior and anterior-posterior direction)
was excluded for dose calculation to this organ-at-risk. As
the mean lung dose was shown to be predictive for radia-
tion induced pulmonary toxicity [28], the mean dose in
this region was calculated (DMean Surr).
The simulation in this study was divided into four parts to
analyse the influence of the parameters motion range,
dose inhomogeneity and motion pattern, separately.
DD x x P D F x d x acc = ′ • ′ ∫ 0() ( ) − (2)
Table 1: Overview of patient data derived from 4D-CT imaging 
and the external breathing signal
Patient Tumor Ø
(mm)
AMax
(mm)
σPDF
(mm)
PMean PDF
(mm)
1 18 11.5 3.8 -1.0
2 18 11.1 2.8 -0.6
3 12 17.4 4.2 -3.1
4 25 4.9 1.8 -0.7
5 40 26.8 7.1 -5.6
6 32 5.5 1.4 -1.2
7 27 3.0 0.8 -0.4
8 15 10.9 2.9 -1.2
9 10 3.6 0.9 -0.1
10 87 . 8 2 . 3 - 1 . 3
Abbreviations: range of the probability density function (PDF) AMax, 
standard deviation of the PDF σPDF, time-weighted mean target 
position PMean: this position is defined as the distance from the 
geometrical centre of the PDFBMC Medical Physics 2008, 8:5 http://www.biomedcentral.com/1756-6649/8/5
Page 5 of 15
(page number not for citation purposes)
Range of breathing motion
The first part of the study systematically quantified the
influence of the motion range on the dose to target. For a
single breathing pattern (PDF#1) and a target size of 20
mm, the motion range AMax was varied ranging from 2
mm to 30 mm. These simulations were performed based
on dose prescriptions P105, P125 and P150, which are
most frequently used in pulmonary and hepatic SBRT.
Margins necessary for compensation of the dose loss due
to breathing motion were calculated.
Breathing pattern
The second part of the study systematically evaluated the
influence of the breathing pattern. For one single target
size of 20 mm and AMax of 15 mm the breathing pattern
was varied with the ten clinically observed PDFs. The sim-
ulation was performed for P105, P125 and P150 and mar-
gins for motion compensation were calculated.
Dose inhomogeneity
The third part of the study systematically evaluated the
influence of the dose inhomogeneity in the target on mar-
gins necessary for compensation of breathing motion.
Dose prescriptions from P102 to P150 were simulated.
This was done exemplary for three different patients (#1,
#5, #8) and the corresponding tumor PDF, AMax  and
tumor size. Simulations for P105, P125 and P150 were
performed using all ten patient data (Table 1). Addition-
ally, the influence of dose inhomogeneity on DMean Surr,
the mean dose to the tumor surrounding region, was eval-
uated.
ITV versus OSI target volume concept
The internal target volume (ITV) concept was evaluated as
this is most commonly used in SBRT treatment: the ITV
encompassed the target during the whole breathing cycle
and the 100% dose was prescribed to cover the ITV.
Illustration of three different dose prescriptions P105, P125 and P150 Figure 2
Illustration of three different dose prescriptions P105, P125 and P150. The minimum dose was set to 100% at the 
edges of the target with maximum doses of 105%, 125% and 150%.
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Workflow of convolution simulation for patient #5 for prescription type P125 (the shaded area represents the target in the  time weighted mean position 5.6 mm) Figure 3
Workflow of convolution simulation for patient #5 for prescription type P125 (the shaded area represents the 
target in the time weighted mean position 5.6 mm). (a) The dose to the target without (dashed line) and with consid-
eration of motion (solid line). (b) The accumulated dose with an additional margin of 4.9 mm for motion compensation.
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Results of the OSI and ITV concepts were compared with
dose prescriptions of P105, P125 and P150.
Results
Range of breathing motion
The first simulation evaluated the influence of the motion
range AMax on the dose to the target. An increasing range
of breathing motion resulted in lower DMin to the target.
For motion compensation, the optimal isocentre position
for equal doses at both edges of the target volume agreed
closely with the time-weighted mean target position for 8
of 10 patients. Differences of 0.9 and 2.1 mm were
observed for patients 3 and 5. These patients showed large
motion amplitudes of 17 and 27 mm with highly asym-
metrical breathing patterns.
A polynomial relationship of second order was found
between  σPDF  and the margin size: for target motion
between 2 mm and 30 mm the margin increased quadrat-
ically (coefficients of determination (COD) 0.99). For
P105, a margin of 2 mm was needed for AMax = 10 mm
and σPDF = 3.4 mm. If the motion (AMax and σPDF) was
twice as large, the margin size increased to 6 mm. Results
for the three different prescriptions are shown in Figure 4.
A higher degree of dose inhomogeneity resulted in smaller
margins for motion compensation. For example, to com-
pensate the dose loss due to target motion of σPDF = 6.8
mm and AMax = 20 mm, margins of 6 mm, 5.5 mm and 2.8
mm were necessary for P105, P125 and P150, respec-
tively. Isodose levels close to the 50% ideally don't move
at all under dose blurring. In Figure 3 it was demon-
strated, that especially smaller isodose (e.g. 65%) levels of
the accumulated dose profile were shifted less than higher
isodose levels (100%).
Breathing pattern
The influence of different breathing patterns on the mar-
gin size was investigated while AMax was maintained con-
Margins for compensation of breathing induced dose loss to the target as a function of target motion (σPDF) for PDF#1 Figure 4
Margins for compensation of breathing induced dose loss to the target as a function of target motion (σPDF) for 
PDF#1.
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stant at 15 mm: due to differences in the shapes of the
PDFs, the σPDF ranged between 3.8 mm and 5 mm. For the
three prescription types (P105, P125 and P150), the data
showed larger margins for increased σPDF. Despite a con-
stant AMax, the margins for motion compensation varied
between 2.7 mm and 4.1 mm for P105. Again, larger mar-
gins were needed for P105 than for P150 (Figure 5). These
results show that σPDF is a more robust parameter to
describe the target motion and PDF shape than Amax
which characterizes only the width of target motion.
Dose inhomogeneity
The third simulation evaluated the influence of dose
inhomogeneity in the target on margins for compensation
of breathing motion. The dose prescription was varied
from P102 to P150, margins were increased until the min-
imum dose to the target was 100%. The results are illus-
trated in Figure 6. Margins were smallest for P150 and
largest for P109 and P105: for AMax of 11.5 mm and target
size of 18 mm (patient #1), margins of 1.3 mm, 2.4 mm
and 2.5 mm were required for P150, P125 and P105,
respectively. The advantage of smaller margins for
increased target dose inhomogeneity was observed for all
three patients but the benefit was more obvious for large
tumor motion.
The investigation of different degrees of dose inhomoge-
neity in the target showed generally an increase in margin
size for more homogeneous target dose. Depending on
the shape of the PDF, we observed a small decrease in
margin size from P105 or P109 to P102 (Figure 6). The
decrease was caused by convolving a gaussian shaped pro-
file with a non symmetric PDF. Before convolution, the
curvature of the static profile was monotonically decreas-
ing from 66% (P150) to 98% (P102) isodose level. This
was not the case for the accumulated dose profile which
was deformed depending on the shape of the PDF. The
distance of the prescription isodose level between static
Margins size as a function of the standard deviation of target motion (σPDF) for the ten clinically observed breathing patterns;  motion range (15 mm) and target size (20 mm) remained constant in this experiment Figure 5
Margins size as a function of the standard deviation of target motion (σPDF) for the ten clinically observed 
breathing patterns; motion range (15 mm) and target size (20 mm) remained constant in this experiment.
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and accumulated profile was largest for P105 and P109
which resulted in the maximum compensation margins.
The distance decreased for larger prescription isodose lev-
els and therefore the necessary margin size was decreasing
as well.
Figure 7 shows the mean dose to the organ-at-risk sur-
rounding the target as a function of dose inhomogeneity
from P150 to P102 for three patients. Motion compensa-
tion with dose inhomogeneities from P105 to P118
resulted in the lowest mean dose to surrounding organ-at-
risk. Despite smaller safety margins in superior-inferior
direction for larger dose inhomogeneity than P118, the
mean dose to the surrounding organ-at-risk increased due
to higher doses in the entrance and exit region of the radi-
ation beams.
The effect of smaller safety margins with increased dose
inhomogeneity was validated for all ten patients (Figure
8).
ITV versus OSI target volume concept
The comparison of motion compensation using the ITV
concept and the OSI concept showed differences for mar-
gins, target dose and DMean Surr (Table 2). Margins for com-
pensation of breathing motion were smaller based on the
OSI concept compared to the ITV concept. As a conse-
quence, the ITV concept over-compensated the effects of
breathing motion with higher than planned doses to the
target: the ITV concept increased DMin to the target by 3.6
± 0.7%, 17.8 ± 4.0%, 37.2 ± 8.9% for P105, P125 and
P150, respectively. Simultaneously, DMean Surr was
increased for the ITV concept compared to the OSI con-
cept.
Margins for compensation of breathing induced dose loss to the target as a function of the dose prescription for three particu- lar patients (#8, #1, #5) Figure 6
Margins for compensation of breathing induced dose loss to the target as a function of the dose prescription 
for three particular patients (#8, #1, #5).
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Discussion
This study used a one-dimensional convolution model to
simulate the effects of breathing induced target motion in
radiotherapy treatment. We allowed dose inhomogeneity
in the target, which is considered as the standard in SBRT
treatment of intra-hepatic and intra-pulmonary tumors
[29]. The dose inhomogeneity was achieved by changing
field size and renormalization of the one-beam profile.
No step-and-shoot segments were used to achieve dose
inhomogeneity. Consequently, the results are of interest
especially for conformal SBRT. However, the concept of
inhomogeneous dose distributions for mobile target vol-
umes may gain relevance for radiotherapy treatment in
general.
The time-weighted mean tumor position was selected as
the isocentre in this study. This set-up ensured, that mini-
mum doses after consideration of breathing motion with-
out addition of extra margins were identical at both
"edges" of the target for nearly all patients. As a conse-
quence, the addition of margins resulted in equal dose
compensation to 100% at both edges of the target. A com-
parable concept with treatment planning based on the
mean tumor position has been described by Wolthaus et
al. [27]. Consequently, the time-weighted mean target
position is considered as the appropriate reference for
treatment planning of target volumes with clinically large
breathing motion.
Influence of PDF shape and target dose inhomogeneity on 
margin size
The shape of the probability density function – i.e. how
long does the target stay at which position – influenced
margins for motion compensation. The correlation
between safety margins and maximum range of tumor
motion was suboptimal: different margins were calcu-
lated for different shapes of the tumor PDF despite identi-
cal motion range. The maximum motion range describes
Accumulated mean dose to the surrounding area DMean Surr as a function of the dose prescription for three patients (#8, #1, #5) Figure 7
Accumulated mean dose to the surrounding area DMean Surr as a function of the dose prescription for three 
patients (#8, #1, #5).
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the width of motion but not the shape of motion pattern.
In all settings the standard deviation of the PDF was
closely correlated to safety margins. This is in agreement
to the findings of Jiang who showed the dose loss due to
motion depends on the steepness of the dose profile and
the shape of the PDF which is described by the standard
deviation [30].
We observed a quadratic relationship between margins for
compensation of motion induced dose loss and the
motion of the tumor expressed by the standard deviation.
The quadratic relationship between safety margins and
tumor motion was observed for all investigated degrees of
dose inhomogeneity in the target volume but was most
pronounced for P105 and least for P150, where a rather
linear relationship between motion and margins was
observed. A similar quadratic relationship has been
described by Engelsman et al. and Sonke et al. [23,31];
these studies were limited to homogeneous dose distribu-
tions, which is the standard in conventionally fraction-
ated radiotherapy.
The margins for compensation of breathing motion were
smaller, if a higher degree of dose inhomogeneity was
allowed in the target volume. Thus increased dose inho-
mogeneity reduced the absolute irradiated volume of the
surrounding organ-at-risk. However, increased dose inho-
mogeneity in the target volume was associated with
Margins for compensation of breathing induced dose loss to the target for all ten clinically observed patients Figure 8
Margins for compensation of breathing induced dose loss to the target for all ten clinically observed patients.
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Table 2: Mean differences between internal target volume 
concept (ITV) and optimization of the surrounding isodose 
(OSI)
P105 P125 P150
Δ DMin in % 3.6 ± 0.7 17.8 ± 4.0 37.1 ± 8.9
Δ Margin in mm 3.3 ± 1.6 3.6 ± 2.3 4.3 ± 3.0
Δ DMean Surr in % 7.8 ± 3.0 6.4 ± 4.3 4.9 ± 3.1
Abbreviations: absolute increase in minimum target dose Δ DMin, 
absolute increase in margin size Δ Margin, absolute increase in mean 
dose to surrounding region Δ DMean SurrBMC Medical Physics 2008, 8:5 http://www.biomedcentral.com/1756-6649/8/5
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increased doses to the target surrounding organ-at-risk in
the entrance and exit beam regions. These contrary effects
of dose inhomogeneity showed an optimum with mini-
mum mean dose to the surrounding organ-at-risk for dose
prescriptions between P105 and P118. The risk of normal
tissue injury should be minimal in this region of dose
inhomogeneity with simultaneously identical minimum
doses to the target.
Such a benefit of inhomogeneous dose distributions for
treatment of pulmonary targets has been described by
Engelsman et al. [32]: an iso-NTCP increase of the tumor
control probability was observed for reduced field sizes
with higher dose inhomogeneity in the target. In accord-
ance to our study, an optimal dose inhomogeneity in the
target volume was observed. Data from that study were
based on phantom measurements with simulated, regular
breathing motion. Results of our study were in agreement,
and confirmed this concept for inhomogeneous dose dis-
tributions based on irregular breathing motion of real
patient data.
The internal target volume concept is most frequently
used in clinical practice: the amplitude of breathing
induced target motion, target positions in end-inhalation
and end-exhalation, define the size of target volume. The
comparison of the ITV and OSI concept ascertained that
the ITV concept over-estimated the influence of breathing
motion [33] with unnecessary large margins. Increased
doses to the normal tissue and higher as planned doses to
the target are consequences.
Limitations of the study
Though convolution calculations are an accepted model
for investigation of spatial and temporal uncertainties in
radiotherapy, limitations of this method are well known
[17,18] and some issues need to be considered for correct
interpretation of results from this study. We did not aim
to give numerical data for motion compensation which
can be directly transferred into clinical practice. The focus
of our work was to show the relation between motion
compensation and a potential benefit of dose inhomoge-
neity.
Tissue inhomogeneities, differences in density between
the solid tumor and the surrounding normal tissue are not
considered. This may be of minor relevance for SBRT treat-
ment of intra-hepatic targets. However, for intra-pulmo-
nary tumors a decreased dose deposit in the pulmonary
tissue of lower density and in the periphery of the solid
tumor is well known [34]. We have recently shown, that
this effect significantly influences the 4D dose calculation
for pulmonary targets [33]: motion of the tumor and of
the surrounding normal tissue resulted in a variant, non-
static dose distribution during the breathing cycle. Model-
ling of such effects with a convolution model is not possi-
ble. Despite this limitation, we decided to perform this
study with the convolution method, because this
approach allowed systematic analysis of the parameters
dose profile, field size, target size, motion range and shape
of the PDF. Such a large number of simulations would not
have been possible with realistic four-dimensional treat-
ment planning.
The simulations in this study were limited to one spatial
dimension. In all ten patients, breathing motion of the
target was largest in superior-inferior direction and conse-
quently, motion in this direction was simulated. How-
ever, breathing motion in other than superior-inferior
direction is well known [1]. With predominantly co-pla-
nar beam set-up the dose gradient is usually less steep in
anterior-posterior and left-right direction compared to
superior-inferior. Subsequently, margins for compensa-
tion of motion in these directions are expected to be even
smaller compared to the margins calculated in this study
[19,30,35].
The external breathing signal was used as surrogate for
generation of the tumor PDF; the range of tumor motion
was evaluated in respiratory correlated CTs. This method
of PDF generation was chosen to obtain realistic tumor
PDFs based on several breathing cycles. It is well known
that the correlation between external surrogate and inter-
nal target motion is inconsistent [8,10]. However, internal
and external motion is usually best correlated for target
motion in superior-inferior direction, which was simu-
lated in our study. Additionally, phase shifts between
internal and external motion are truly relevant for 4D-CT
reconstruction and gated radiotherapy, but such phase
shifts would have no influence on the results of our study.
Consequently, this procedure is not considered as relevant
for interpretation of results of our study: the benefit of
increased dose inhomogeneity in terms of reduced safety
margins for motion compensation was observed for all
patients with various shapes and ranges of the tumor tra-
jectories.
The simulation was based on one respiratory correlated
CT acquired for treatment planning. Inter-fractional
changes of the patients' breathing motion and breathing
pattern are not considered. However, several studies have
shown that one single respiratory correlated planning CT
study was representative for the duration for a SBRT and
conventionally fractionated treatment course [36-38].
The PDF binning was set to 10 bins for each PDF which
resulted in different PDF resolutions in space depending
on the maximum motion amplitude. The choice was
based on the fact, that in clinical routine always the sameBMC Medical Physics 2008, 8:5 http://www.biomedcentral.com/1756-6649/8/5
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number (8–10) of respiration phases is chosen for recon-
struction of the 4D-CT.
Clinical consequences
Optimal sparing of the organ-at-risk surrounding the tar-
get was achieved for dose prescriptions P105 to P118. For
higher dose prescriptions, the effect of smaller safety mar-
gins was overcompensated by increased doses in the
entrance and exit regions of the radiation beams. The
mean dose to the surrounding organ-at-risk was the basis
for this conclusion. Recently however, several studies have
shown that very small doses between 5 Gy and 13 Gy [39-
41] are most predictive for radiation induced pneumoni-
tis. If this were true the pulmonary tissue in the entrance
and exit regions of the radiation beams would be "sacri-
ficed" regardless of the dose homogeneity in the target
volume. In such a scenario, sparing of lung tissue in supe-
rior-inferior direction would be more clinically relevant
with the consequence of a benefit for dose inhomogenei-
ties greater than P125.
Two recent studies in the literature described four-dimen-
sional treatment planning using respiratory correlated CT.
These studies used the ITV target volume concept for SBRT
of pulmonary [33] and liver tumors [42] and a compari-
son between dose inhomogeneity of P125 and P150 was
performed in both studies. These studies confirmed that
an increased dose inhomogeneity resulted in increased
doses to the target without a significantly increased dose
the surrounding organs-at-risk. These conclusions support
the findings in our study: the concept of inhomogeneous
dose distributions should be developed further in the
future.
Margins in our study were calculated for compensation of
intra-fractional uncertainties of the target position, only.
Other uncertainties in the process of treatment planning
and treatment delivery need to be compensated with extra
margins. Uncertainties in image acquisition and contour-
ing of mobile targets require additional margins. Even
high-precision stereotactic patient positioning was shown
to result in large errors of the target position especially
because of base-line shifts of the tumor independently
from the bony anatomy [37,38,43-45]: decreased tumor
control probability and increased risk of damage to adja-
cent critical structures are consequences [46,47]. The
effects of such set-up errors on the dose to the target are
expected to be more pronounced for treatment planning
with a significant dose inhomogeneity in the target vol-
ume and consequently steep dose gradients close to the
tumor. Image-guidance has been effective for compensa-
tion of these inter-fractional uncertainties and is consid-
ered as prerequisite for such high-precision radiotherapy
[11,36,48].
It is essential, that such aggressive protocols with
increased maximum doses need to be balanced with clin-
ical, patient specific factors. Whereas high dose inhomo-
geneity might be clinically acceptable for targets in the
periphery of the lung, one would be cautious for centrally
located targets [49]. However, it is clear that the way of
dose prescription gives an additional degree of freedom in
treatment planning to the physician and the physicist.
Conclusion
It was demonstrated that the time-weighted mean tumor
position and the standard deviation of breathing induced
target motion are the most relevant parameters in radio-
therapy treatment planning of mobile targets. A quadratic
relationship between motion and margins for compensa-
tion of dose loss was observed for various degrees of dose
inhomogeneity within the target volume. A margin reduc-
tion was possible by allowing an inhomogeneous dose
distribution in the target. The internal target volume con-
cept over-compensated breathing motion with the conse-
quence of higher than planned doses to the target and
increased dose to the lung.
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